Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women
This study has been completed.
Study NCT00705679
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received on June 24, 2008.
Last Updated on September 7, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
